September 5th Options Now Available For Sarepta Therapeutics (SRPT)

The article analyzes specific options strategies for Sarepta Therapeutics (SRPT), detailing a $12.00 strike cash-secured put that offers an effective cost basis of $10.55 and a 102.57% annualized return if it expires worthless (64% probability). It also examines a $13.50 strike covered call providing a potential 23.97% total return if called away, or a 108.38% annualized return if it expires worthless (46% probability). These strategies leverage high implied volatilities (137-141%) relative to SRPT's 101% trailing historical volatility, presenting opportunities for enhanced yield or strategic entry/exit points.

Analysis

The options market for Sarepta Therapeutics (SRPT) currently exhibits significantly elevated implied volatility, creating opportunities for income generation and strategic stock acquisition. Implied volatility for the analyzed put and call contracts stands at 137% and 141% respectively, a notable premium over the stock's actual trailing twelve-month volatility of 101%. This pricing environment makes selling options particularly attractive. For investors looking to initiate a position, selling the $12.00 strike put contract offers a way to collect a $1.45 premium, effectively lowering the cost basis to $10.55 per share if assigned, a discount to the current $12.14 price. The probability of this put expiring worthless is calculated at 64%, which would result in a 102.57% annualized yield on the cash commitment. For existing shareholders, a covered call strategy at the $13.50 strike could generate a 12.77% return boost (108.38% annualized) if the option expires worthless, with a 46% probability of this outcome. Alternatively, if the stock is called away, the strategy provides a total return of 23.97%, capping further upside.

Key Decisions for Investors

• Investors bullish on SRPT but seeking a lower entry point should consider selling the $12.00 cash-secured put to potentially acquire shares at an effective cost of $10.55 or generate a substantial yield if the stock remains above the strike price.
• Current SRPT shareholders could implement a covered call strategy by selling the $13.50 call to generate significant income, but must be comfortable with forgoing upside potential beyond a 23.97% total return if the stock is called away.
• Traders should recognize that the high premium in implied volatility over historical volatility is the primary driver of these attractive yields, but it also signals market expectations for significant price movement, introducing risk that the underlying stock could move sharply against the position.